Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
Usually their sleep is an REM sleep
BPC-157 + TB-500 Dosage Chart The BPC-157 + TB-500 peptide blend is dosed at 600 mcg800 mcg daily via subcutaneous injection in educational protocols
Harlev A, Agarwal A, Gunes SO, Shetty A, du Plessis SS
Head-to-Head: Capsules vs Injection vs Alternatives Operational Guide: Dosing, Reconstitution, and Label Literacy For Capsules Typical commercially available capsule doses are 250 mcg to 500 mcg per capsule